Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
23.90
-0.33 (-1.36%)
Apr 29, 2026, 11:28 AM EDT - Market open
Damora Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 257.62 | 14.18 | 21.47 | 32.79 | 62.56 | Upgrade
|
| Short-Term Investments | - | - | 11.69 | 27.44 | 37.63 | Upgrade
|
| Cash & Short-Term Investments | 257.62 | 14.18 | 33.15 | 60.22 | 100.19 | Upgrade
|
| Cash Growth | 1717.45% | -57.24% | -44.95% | -39.89% | -38.75% | Upgrade
|
| Other Receivables | 0.9 | 0.88 | 1.72 | 1.38 | 2.28 | Upgrade
|
| Receivables | 0.9 | 0.88 | 1.72 | 1.38 | 2.28 | Upgrade
|
| Prepaid Expenses | 0.58 | 0.59 | 0.77 | 0.81 | 1.73 | Upgrade
|
| Other Current Assets | 1.32 | 1.19 | 1.13 | 1.5 | 5.9 | Upgrade
|
| Total Current Assets | 260.42 | 16.84 | 36.77 | 63.91 | 110.1 | Upgrade
|
| Property, Plant & Equipment | 0.1 | 0.13 | 0.33 | 1.17 | 1.04 | Upgrade
|
| Long-Term Investments | - | - | - | 5.83 | 9.05 | Upgrade
|
| Other Long-Term Assets | - | 0.16 | 1.13 | 2.28 | 2.03 | Upgrade
|
| Total Assets | 260.53 | 17.13 | 38.23 | 73.19 | 122.22 | Upgrade
|
| Accounts Payable | 17.67 | 0.38 | 1.7 | 3.35 | 1.53 | Upgrade
|
| Accrued Expenses | 0.72 | 0.32 | 1.67 | 6.74 | 2.18 | Upgrade
|
| Current Portion of Leases | 0.02 | 0.01 | 0.18 | 0.48 | 0.4 | Upgrade
|
| Other Current Liabilities | 1.67 | 0.49 | 2.27 | 0.54 | 0.44 | Upgrade
|
| Total Current Liabilities | 20.07 | 1.2 | 5.83 | 11.11 | 4.54 | Upgrade
|
| Long-Term Leases | 0.05 | 0.06 | 0.07 | 0.33 | 0.45 | Upgrade
|
| Other Long-Term Liabilities | 0.03 | 0.04 | - | - | - | Upgrade
|
| Total Liabilities | 20.15 | 1.3 | 5.9 | 11.44 | 4.99 | Upgrade
|
| Additional Paid-In Capital | 310.69 | 291.9 | 288.04 | 279.73 | 273.66 | Upgrade
|
| Retained Earnings | -487.36 | -277.52 | -256.09 | -217.74 | -156.11 | Upgrade
|
| Comprehensive Income & Other | 0.8 | 0.1 | 0.38 | -0.24 | -0.32 | Upgrade
|
| Total Common Equity | -175.87 | 14.47 | 32.33 | 61.75 | 117.22 | Upgrade
|
| Shareholders' Equity | 240.38 | 15.83 | 32.33 | 61.75 | 117.22 | Upgrade
|
| Total Liabilities & Equity | 260.53 | 17.13 | 38.23 | 73.19 | 122.22 | Upgrade
|
| Total Debt | 0.07 | 0.07 | 0.25 | 0.8 | 0.85 | Upgrade
|
| Net Cash (Debt) | 257.56 | 14.1 | 32.9 | 65.25 | 108.39 | Upgrade
|
| Net Cash Growth | 1726.38% | -57.14% | -49.58% | -39.80% | -33.37% | Upgrade
|
| Net Cash Per Share | 188.96 | 12.19 | 30.96 | 64.20 | 107.27 | Upgrade
|
| Filing Date Shares Outstanding | 60.3 | 1.32 | 1.08 | 1.03 | 1.01 | Upgrade
|
| Total Common Shares Outstanding | 1.6 | 1.32 | 1.08 | 1.03 | 1.01 | Upgrade
|
| Working Capital | 240.36 | 15.64 | 30.94 | 52.8 | 105.56 | Upgrade
|
| Book Value Per Share | -110.10 | 10.99 | 29.81 | 60.18 | 116.01 | Upgrade
|
| Tangible Book Value | -175.87 | 14.47 | 32.33 | 61.75 | 117.22 | Upgrade
|
| Tangible Book Value Per Share | -110.10 | 10.99 | 29.81 | 60.18 | 116.01 | Upgrade
|
| Machinery | 0.11 | 0.11 | 0.11 | 0.42 | 0.22 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.